Guggenheim Capital LLC Lowers Stock Holdings in Mirati Therapeutics, Inc. (NASDAQ:MRTX)

Guggenheim Capital LLC reduced its stake in Mirati Therapeutics, Inc. (NASDAQ:MRTX – Get Rating) by 23.7% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 24,340 shares of the biotechnology company’s stock after selling 7,570 shares during the quarter. Guggenheim Capital LLC’s holdings in Mirati […]

Related Keywords

China ,San Diego ,California ,United States ,Juliem Cherrington ,Charlesm Baum , ,Securities Exchange Commission ,Nasdaq ,Mirati Therapeutics Inc ,Guggenheim Capital ,Quadrant Capital Group ,Exchange Commission ,Needham Company ,Jpmorgan Chase Co ,Advisor Group Holdings Inc ,Wealth Advisors ,China Universal Asset Management Co ,Wipfli Financial Advisors ,Barclays ,Citigroup ,Mirati Therapeutics ,Get Rating ,Universal Asset Management ,Financial Advisors ,Group Holdings ,Capital Group ,Director Julie ,Mirati Therapeutics Daily ,Nasdaq Mrtx ,Mrtx ,Medical ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,